NCT05844189

Brief Summary

The hypothesis of this study is that capacitive-resistive monopolar radiofrecuency (CRMRF) with vaginal manual physiotherapy improves sexual health in young women suffering from dyspareunia (pain during sexual intercourse). The realization of studies that help to know the therapeutic possibilities in the field of dyspareunia seems necessary, taking into account the number of women affected, as well as the deficits of scientific evidence in this field. The main objective of this study is to analyze whether the use of CRMRF brings additional benefits to the results of manual therapy on dyspareunia in young women. Likewise, it intends to analyze the data for two secondary objectives:

  1. 1.Analyze changes in different areas of women's sexual function in young people with dyspareunia through treatment (Desire, arousal, lubrication, orgasm, satisfaction and pain).
  2. 2.Study if the use of CRMRF is an added benefit in personal perception while receiving treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 25, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
Last Updated

May 6, 2023

Status Verified

April 1, 2023

Enrollment Period

1.3 years

First QC Date

April 25, 2023

Last Update Submit

April 25, 2023

Conditions

Keywords

Capacitive Resistive Monopolar RadiofrecuencySexual Dysfunction, PhysiologicalPelvic floorPhysical Therapy ModalitiesMusculoskeletal Manipulations

Outcome Measures

Primary Outcomes (1)

  • Pain in sexual intercourse

    The pain was described using the anamnesis, the pain score of the "FSFI" scale (Female Sexual Function Index) and the scale of pain "VAS" (Visual Analogue Scale) that is a numerical rating scale that goes from zero to ten. Zero represents the absence of pain and ten the greatest pain that the patient can imagine. The pain was described also using vaginal dilators and seeing at which measure the pain begins.

    Five months

Secondary Outcomes (5)

  • Female sexual function

    Five months

  • Quality of sexual relations

    Five months

  • Problems with vaginal penetration

    Five months

  • State of the musculature of the pelvic floor

    Five months

  • Perception of treatment

    Five months

Study Arms (2)

Treatment Group

EXPERIMENTAL

CRMRF and physical therapy modalities on pelvic floor.

Procedure: Physical therapy modalities on pelvic floor (manual therapy)Device: CRMRF

Sham Group

SHAM COMPARATOR

Only physical therapy modalities on pelvic floor. In this Arm the CRMRF is off.

Procedure: Physical therapy modalities on pelvic floor (manual therapy)Device: Sham CRMRF

Interventions

Intravaginal treatment (perineal massage)

Sham GroupTreatment Group
CRMRFDEVICE

CRMRF application on pelvic floor: * Externally over the urogenital triangle of the patient, * Intracavitary application (intravaginal) * Externally over the urogenital triangle of the patient while the physical therapist performs the intracavitary manual therapy (intravaginal), The device used is named "Intradermik" and it is the portable CRMRF device of the brand RÖS'S Estética SL. It has these features: * Frequency: 448kHz * Capacitive power: 450 voltamperes * Resistive power: 200 watts

Treatment Group

The physical therapist applies the same treatment as the Treatment Group but the device is switched off.

Sham Group

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women between 18 and 30 years old.
  • Women who have pain during sexual intercourse, classified as dyspareunia superficial in the last 12 months.

You may not qualify if:

  • Use of antidepressants.
  • Pregnancy and lactation.
  • Cardiac pathologies.
  • Epilepsy.
  • Acute inflammatory process.
  • Pacemaker.
  • Skin or mucous infections in the urogenital area.
  • Any alteration that prevents the understanding of the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Escoles Universitaries Gimbernat

Sant Cugat del Vallès, Barcelona, 08174, Spain

Location

Related Publications (16)

  • Thomten J. Living with genital pain: Sexual function, satisfaction, and help-seeking among women living in Sweden. Scand J Pain. 2014 Jan 1;5(1):19-25. doi: 10.1016/j.sjpain.2013.10.002.

  • Elmerstig E, Wijma B, Swahnberg K. Young Swedish women's experience of pain and discomfort during sexual intercourse. Acta Obstet Gynecol Scand. 2009;88(1):98-103. doi: 10.1080/00016340802620999.

  • Hendrickx L, Gijs L, Enzlin P. Age-related prevalence rates of sexual difficulties, sexual dysfunctions, and sexual distress in heterosexual women: results from an online survey in flanders. J Sex Med. 2015 Feb;12(2):424-35. doi: 10.1111/jsm.12725. Epub 2014 Oct 27.

  • Mitchell KR, Geary R, Graham CA, Datta J, Wellings K, Sonnenberg P, Field N, Nunns D, Bancroft J, Jones KG, Johnson AM, Mercer CH. Painful sex (dyspareunia) in women: prevalence and associated factors in a British population probability survey. BJOG. 2017 Oct;124(11):1689-1697. doi: 10.1111/1471-0528.14518. Epub 2017 Jan 25.

  • Demirel G, Golbasi Z. Effect of perineal massage on the rate of episiotomy and perineal tearing. Int J Gynaecol Obstet. 2015 Nov;131(2):183-6. doi: 10.1016/j.ijgo.2015.04.048. Epub 2015 Jul 26.

  • Leon-Larios F, Corrales-Gutierrez I, Casado-Mejia R, Suarez-Serrano C. Influence of a pelvic floor training programme to prevent perineal trauma: A quasi-randomised controlled trial. Midwifery. 2017 Jul;50:72-77. doi: 10.1016/j.midw.2017.03.015. Epub 2017 Mar 27.

  • Takeuchi S, Horiuchi S. Randomised controlled trial using smartphone website vs leaflet to support antenatal perineal massage practice for pregnant women. Women Birth. 2016 Oct;29(5):430-435. doi: 10.1016/j.wombi.2016.01.010. Epub 2016 Feb 19.

  • Spottorno J, Gonzalez de Vega C, Buenaventura M, Hernando A. Influence of electrodes on the 448 kHz electric currents created by radiofrequency: A finite element study. Electromagn Biol Med. 2017;36(3):306-314. doi: 10.1080/15368378.2017.1354015. Epub 2017 Jul 31.

  • Silva AP, Montenegro ML, Gurian MB, Mitidieri AM, Lara LA, Poli-Neto OB, Rosa E Silva JC. Perineal Massage Improves the Dyspareunia Caused by Tenderness of the Pelvic Floor Muscles. Rev Bras Ginecol Obstet. 2017 Jan;39(1):26-30. doi: 10.1055/s-0036-1597651. Epub 2016 Dec 27.

  • Kumaran B, Watson T. Thermal build-up, decay and retention responses to local therapeutic application of 448 kHz capacitive resistive monopolar radiofrequency: A prospective randomised crossover study in healthy adults. Int J Hyperthermia. 2015;31(8):883-95. doi: 10.3109/02656736.2015.1092172. Epub 2015 Nov 2.

  • Trahan J, Leger E, Allen M, Koebele R, Yoffe MB, Simon C, Alappattu M, Figuers C. The Efficacy of Manual Therapy for Treatment of Dyspareunia in Females: A Systematic Review. J Womens Health Phys Therap. 2019 Jan-Mar;43(1):28-35. doi: 10.1097/jwh.0000000000000117.

  • Sanchez-Sanchez F, Ferrer-Casanova C, Ponce-Buj B, Sipan-Sarrion Y, Jurado-Lopez AR, San Martin-Blanco C, Tijeras-Ubeda MJ, Ferrandez Infante A. [Design and validation of the second edition of the Women's Sexual Function Questionnaire, FSM-2]. Semergen. 2020 Jul-Aug;46(5):324-330. doi: 10.1016/j.semerg.2020.01.004. Epub 2020 Mar 18. Spanish.

  • Sanchez-Sanchez B, Navarro-Brazalez B, Arranz-Martin B, Sanchez-Mendez O, de la Rosa-Diaz I, Torres-Lacomba M. The Female Sexual Function Index: Transculturally Adaptation and Psychometric Validation in Spanish Women. Int J Environ Res Public Health. 2020 Feb 5;17(3):994. doi: 10.3390/ijerph17030994.

  • Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208. doi: 10.1080/009262300278597.

  • Fernandez-Cuadros ME, Kazlauskas SG, Albaladejo-Florin MJ, Robles-Lopez M, Laborda-Delgado A, de la Cal-Alvarez C, Perez-Moro O. [Effectiveness of multimodal rehabilitation (biofeedback plus capacitive-resistive radiofrequency) on chronic pelvic pain and dyspareunia: prospective study and literature review]. Rehabilitacion (Madr). 2020 Jul-Sep;54(3):154-161. doi: 10.1016/j.rh.2020.02.005. Epub 2020 May 6. Spanish.

  • Pla AA, Andreu-Povar A, Fabbi L, Esquirol-Caussa J, Lleberia-Juanos J, Gil-Moreno A, Omana MC. Evaluation of the efficacy of Capacitive Resistive Monopolar Radiofrequency at 448 kHz in the physiotherapeutic treatment of female dyspareunia. Contemp Clin Trials Commun. 2025 Jan 10;44:101433. doi: 10.1016/j.conctc.2025.101433. eCollection 2025 Apr.

MeSH Terms

Conditions

DyspareuniaSexual Dysfunction, Physiological

Interventions

Musculoskeletal Manipulations

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGenital Diseases, MaleMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Anna Abelló Pla, MSc

    Escoles Universitaries Gimbernat

    PRINCIPAL INVESTIGATOR
  • Jordi Esquirol Caussa, PhD

    Escoles Universitaries Gimbernat

    STUDY DIRECTOR
  • Judit Lleberia

    Universitat Autònoma de Barcelona

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2023

First Posted

May 6, 2023

Study Start

November 5, 2021

Primary Completion

February 9, 2023

Study Completion

February 9, 2023

Last Updated

May 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations